List of Excipients in API primaquine phosphate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing primaquine phosphate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | CARNAUBA WAX | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | CELLULOSE, MICROCRYSTALLINE | |
| Sanofi-Aventis US LLC | PRIMAQUINE PHOSPHATE | primaquine phosphate | 0024-1596 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing primaquine phosphate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 | CELLULOSE, MICROCRYSTALLINE |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 | FD&C BLUE NO. 2 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 | FD&C RED NO. 40 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for primaquine phosphate
Excipient focus: CARNAUBA WAX
primaquine phosphate drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
primaquine phosphate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
primaquine phosphate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
primaquine phosphate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
primaquine phosphate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
primaquine phosphate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
primaquine phosphate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
primaquine phosphate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
primaquine phosphate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
primaquine phosphate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
primaquine phosphate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
primaquine phosphate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
primaquine phosphate drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
primaquine phosphate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
primaquine phosphate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
primaquine phosphate drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
primaquine phosphate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
primaquine phosphate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| AvKARE | primaquine phosphate | 42291-510 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
primaquine phosphate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | primaquine phosphate | 42291-510 |
| Ingenus Pharmaceuticals LLC | primaquine phosphate | 50742-191 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
primaquine phosphate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | primaquine phosphate | 33261-671 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-721 |
| Golden State Medical Supply Inc | primaquine phosphate | 60429-035 |
| >Company | >Ingredient | >NDC |
primaquine phosphate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | primaquine phosphate | 0024-1596 |
| AvKARE | primaquine phosphate | 42291-510 |
| PD-Rx Pharmaceuticals Inc | primaquine phosphate | 43063-225 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
